Bio Pharma Dive
AUGUST 14, 2020
Biotech companies have raised nearly $10 billion from 45 initial public offerings this year, with CureVac's fueling the development of an experimental coronavirus vaccine.
Pharma Mirror
AUGUST 14, 2020
Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
AUGUST 14, 2020
Both the U.S. and U.K. have aggressively signed preorder deals with vaccine developers. An agreement with AstraZeneca is the EU's first.
Pharma Mirror
AUGUST 14, 2020
QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
AUGUST 14, 2020
After ditching its home-grown attempt at a coronavirus contact-tracing app for smartphones, the UK is ready to start pilot trials of a second version based on a platform developed by Apple and Google. The new NHS Test and Trace app is intended to be used as an add-on to the controversial national and local contact-tracing service, and was due to start initial trials yesterday on the Isle of Wight and among a group of NHS volunteers.
Pharma Mirror
AUGUST 14, 2020
The positive impacts of pharmacists in supporting medication without harm are described in a new publication from the International Pharmaceutical Federation (FIP) released today. The World Health Organization reports that one in four patients is harmed by the care they receive in primary and ambulatory care settings, including harm from medicines. It estimates the global.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
AUGUST 14, 2020
While the COVID-19 pandemic has disrupted the way consumers shop and food manufacturers operate, food safety remains a top priority for all stakeholders. The entire food supply chain is committed to meeting this expectation despite the fact that our new normal is changing from day-to-day. Many companies have successfully transitioned their meetings, events and even happy hours to virtual platforms to meet social distancing recommendations.
Pharma Marketing Network
AUGUST 14, 2020
2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.
Scienmag
AUGUST 14, 2020
Discovery could lead to new screening tests and potential treatments Credit: Cincinnati Children’s Two common variants in the KIF3A gene increase the risk of young children having a dysfunctional skin barrier and developing the skin condition atopic dermatitis. This, in turn, can allow environmental exposures to more easily cross the skin barrier and contribute to […].
pharmaphorum
AUGUST 14, 2020
Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. Consumer advocacy group Public Citizen has slammed the amount Moderna is charging the US for the mRNA-1273 vaccine, saying that as taxpayer money had funded 100% of the work done to bring it to market the US is “paying twice” for the shot.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
AUGUST 14, 2020
Company will manufacture over 25% more doses than previously planned
pharmaphorum
AUGUST 14, 2020
Screening women for breast cancer in their 40s rather than their 50s could save lives, say the authors of a new Lancet Oncology study, although that finding has been challenged by other experts. Lowering the age that women start to routinely get mammograms was associated with a relative reduction in breast cancer mortality without leading to ‘over-diagnosis’ – in other words detecting minor changes that may not turn into full-blown cancers – according to the scientists.
The Pharma Data
AUGUST 14, 2020
Photo by Senior Airman Areca Wilson. Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s coronavirus vaccine. Many countries have criticised Russia pursuit for a COVID-19 cure, which has skipped Phase 3 trials before giving the vaccine regulatory approval. It seems Chuchalin had tried and failed to block its registration on safety grounds.
Scienmag
AUGUST 14, 2020
Credit: WSU PULLMAN, Wash. – Scientists have found clear indicators for how the interaction of poor hygiene and antibiotic use contribute to the colonization of antimicrobial-resistant (AMR) bacteria in humans, a problem that contributes to hundreds of thousands of deaths annually. The findings by researchers at Washington State University’s Paul G.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
AUGUST 14, 2020
Deals agreed with Janssen and Novavax for another 90 million doses
Scienmag
AUGUST 14, 2020
Bishop Peder Winstrup of Lund, Sweden passed away in the winter of 1679 at the age of 74 and was interred in a crypt at Lund Cathedral; three centuries later, his astonishingly well-preserved remains provide insights to the origins of tuberculosis Credit: Orf3us / CC BY-SA ([link] When Anthropologist Caroline Arcini and her colleagues at […].
pharmaphorum
AUGUST 14, 2020
Global branding firm Conran Design Group has appointed former Wolff Olins chief operating officer Christina Falzano as its US managing director. She brings over 20 years’ experience in brand strategy and marketing to her new role at the Havas -owned communications agency. Before joining brand consultancy Wolff Olins – where she oversaw work for Google , Wikipedia, Uber, Showtime and Spotify, Falzano served as managing director for Brand Union (now merged into Superunion).
Scienmag
AUGUST 14, 2020
Credit: Credit: Ursala Rack A New Zealand-led international study of the crabeater seal population in Antarctica aims to understand environmental impacts on one of the southern-most mammals in the world. With funding from The Pew Charitable Trusts, University of Canterbury (UC) scientists have been using satellite images of Antarctica and the power of citizen science […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
AUGUST 14, 2020
Clinical trial programme resumes after safety concerns
NY Times
AUGUST 14, 2020
Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Scienmag
AUGUST 14, 2020
Credit: SDO/AIA +SOHO/LASCO COR1+COR2 Scientists at Skolkovo Institute of Science and Technology (Skoltech), together with colleagues from the Karl-Franzens University of Graz & the Kanzelhöhe Observatory (Austria), Jet Propulsion Laboratory of California Institute of Technology (USA), Helioresearch (USA) and Space Research Institute of the Russian Academy of Sciences (Russia) developed a method to study fast […].
Pharma Marketing Network
AUGUST 14, 2020
2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
AUGUST 14, 2020
Study of three California cities finds that past discriminatory housing practices may be impacting maternal and infant health today Past discriminatory housing practices may play a role in perpetuating the significant disparities in infant and maternal health faced by people of color in the U.S., suggests a new study by researchers at the University of […].
The Pharma Data
AUGUST 14, 2020
The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that Russia has granted regulatory approval for a COVID-19 vaccine while researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to coronavirus patients, despite a general lack of evidence for its effectiveness.
Scienmag
AUGUST 14, 2020
Understanding the mechanisms that impair lymphatics growth and fat digestion in the small intestine Credit: IBS You have just enjoyed a delicious summer BBQ. After approximately eight hours, food molecules reach your small intestine, where specialized lymph capillaries, called lacteals, absorb fat nutrients. Lacteals are different from other lymphatics, as they continue to regenerate during […].
The Pharma Data
AUGUST 14, 2020
Image copyright. Getty Images. Parents are being urged to make sure their children are up-to-date with all their routine vaccinations. The Local Government Association said high vaccine uptake could prevent infections and stop pressure being piled on the NHS. The childhood vaccination programme is continuing as normal while jabs given in school are being rescheduled.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
AUGUST 14, 2020
UAB and Polish researchers propose that the COVID-19 virus acts as a microRNA “sponge” to deplete miRNA levels in ways that aid viral replication and stymie the host immune response. Credit: UAB BIRMINGHAM, Ala. – Why is the COVID-19 virus deadly, while many other coronaviruses are fairly innocuous and just cause colds? A team of […].
The Pharma Data
AUGUST 14, 2020
The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of their vaccine candidates to protect against COVID-19 infection. . One of the announced deals was to reserve 30 million doses of Ad26.COV2.S, the COVID-19 vaccine candidate developed by Janssen, the pharmaceutical subsidiary of J&J, for not-for-profit emergency pandemic use.
Scienmag
AUGUST 14, 2020
Credit: Instituto de Agrobiotecnología del Litoral The programme is funded by the German-Argentinean University Centre (DAHZ-CUAA). Dr. Regina Mencia from Argentina was the first doctoral student to complete her doctorate under this programme at the beginning of this year. The success of her German-Argentinean cooperation has now been crowned by a joint publication in the […].
The Pharma Data
AUGUST 14, 2020
Company will manufacture over 25% more doses than previously planned. AstraZeneca has announced the first shipment of Flumist Quadrivalent vaccine doses have been sent to the US for the upcoming influenza season. Flumist is currently the only nasal-spray flu vaccine and is indicated for use in individuals aged two through to 49. The US Centres for Disease Control and Prevention (CDC) has recently highlighted the importance of flu vaccination rates for the 2020-21 season, in a b
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
201 
Let's personalize your content